Circulating smooth muscle progenitor cells in arterial remodeling

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 2, 2011, Pages 273-279

  Daniel, Jan Marcus ^a   Sedding, Daniel G ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Neointima formation; Smooth muscle; Smooth muscle progenitor cell; Transplant arteriosclerosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD14 ANTIGEN; CD68 ANTIGEN; CELL SURFACE MARKER; MYOSIN HEAVY CHAIN; MEMBRANE ANTIGEN;

ARTERIAL WALL THICKNESS; ARTERIOSCLEROSIS; ATHEROGENESIS; ATHEROSCLEROSIS; BONE MARROW; CELL MIGRATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GRAFT DYSFUNCTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MARKER GENE; MONONUCLEAR CELL; NEOINTIMA; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE PROGENITOR CELL; SPINDLE CELL; STEM CELL; TRANSPLANT GRAFT VASCULOPATHY; VASCULAR SMOOTH MUSCLE; ANIMAL; ARTERY; BONE MARROW CELL; CELL DIFFERENTIATION; CYTOLOGY; METABOLISM; MYOBLAST; PATHOLOGY;

ANIMALS; ANTIGENS, SURFACE; ARTERIES; ARTERIOSCLEROSIS; BONE MARROW CELLS; CELL DIFFERENTIATION; HUMANS; MYOBLASTS, SMOOTH MUSCLE; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; STEM CELLS;

EID: 79151478174     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.10.030     Document Type: Review

References (59)

1. Dzau V.J., Braun-Dullaeus R.C., Sedding D.G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 2002, 8(11):1249-1256.
2. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004, 84(3):767-801.
3. Schwartz S.M., Virmani R., Rosenfeld M.E. The good smooth muscle cells in atherosclerosis. Curr Atheroscler Rep 2000, 2(5):422-429.
4. Davies M.J., Richardson P.D., Woolf N., Katz D.R., Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993, 69(5):377-381.
5. Majesky M.W. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol Jun 2007, 27(6):1248-1258.
6. Murry C.E., Gipaya C.T., Bartosek T., Benditt E.P., Schwartz S.M. Monoclonality of smooth muscle cells in human atherosclerosis. Am J Pathol 1997, 151(3):697-705.
7. Matthews C., Gorenne I., Scott S., Figg N., Kirkpatrick P., Ritchie A., et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res 2006, 99(2):156-164.
8. Sainz J., Al Haj Zen A., Caligiuri G., Demerens C., Urbain D., Lemitre M., et al. Isolation of "side population" progenitor cells from healthy arteries of adult mice. Arterioscler Thromb Vasc Biol 2006, 26(2):281-286.
9. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275(5302):964-967.
10. Simper D., Stalboerger P.G., Panetta C.J., Wang S., Caplice N.M. Smooth muscle progenitor cells in human blood. Circulation 2002, 106(10):1199-1204.
11. Saiura A., Sata M., Hirata Y., Nagai R., Makuuchi M. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 2001, 7(4):382-383.
12. Bentzon J.F., Weile C., Sondergaard C.S., Hindkjaer J., Kassem M., Falk E. Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol 2006, 26(12):2696-2702.
13. Daniel J.M., Bielenberg W., Stieger P., Weinert S., Tillmanns H., Sedding D.G. Time-course analysis on the differentiation of bone marrow-derived progenitor cells into smooth muscle cells during neointima formation. Arterioscler Thromb Vasc Biol 2010, 30(10):1890-1896.
14. Kumar A.H., Metharom P., Schmeckpeper J., Weiss S., Martin K., Caplice N.M. Bone marrow-derived CX3CR1 progenitors contribute to neointimal smooth muscle cells via fractalkine CX3CR1 interaction. FASEB J 2010, 24(1):81-92.
15. Subramanian P., Karshovska E., Reinhard P., Megens R.T., Zhou Z., Akhtar S., et al. Lysophosphatidic Acid Receptors LPA1 and LPA3 Promote CXCL12-Mediated Smooth Muscle Progenitor Cell Recruitment in Neointima Formation. Circ Res. 2010.
16. Sugiyama S., Kugiyama K., Nakamura S., Kataoka K., Aikawa M., Shimizu K., et al. Characterization of smooth muscle-like cells in circulating human peripheral blood. Atherosclerosis 2006, 187(2):351-362.
17. Metharom P., Liu C., Wang S., Stalboerger P., Chen G., Doyle B., et al. Myeloid lineage of high proliferative potential human smooth muscle outgrowth cells circulating in blood and vasculogenic smooth muscle-like cells in vivo. Atherosclerosis 2008, 198(1):29-38.
18. Deb A., Patterson C. Hard luck stories: the reality of endothelial progenitor cells continues to fall short of the promise. Circulation 2010, 121(7):850-852.
19. Xu Q. Stem cells and transplant arteriosclerosis. Circ Res 2008, 102(9):1011-1024.
20. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109(5):1801-1809.
21. Hristov M., Zernecke A., Schober A., Weber C. Adult progenitor cells in vascular remodeling during atherosclerosis. Biol Chem 2008, 389(7):837-844.
22. Simper D., Mayr U., Urbich C., Zampetaki A., Prokopi M., Didangelos A., et al. Comparative proteomics profiling reveals role of smooth muscle progenitors in extracellular matrix production. Arterioscler Thromb Vasc Biol 2010, 30(7):1325-1332.
23. Hagensen M.K., Shim J., Thim T., Falk E., Bentzon J.F. Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. Circulation 2010, 121(7):898-905.
24. van de Rijn M., Heimfeld S., Spangrude G.J., Weissman I.L. Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family. Proc Natl Acad Sci USA 1989, 86(12):4634-4638.
25. Mayr M., Zampetaki A., Sidibe A., Mayr U., Yin X., De Souza A.I., et al. Proteomic and metabolomic analysis of smooth muscle cells derived from the arterial media and adventitial progenitors of apolipoprotein E-deficient mice. Circ Res 2008, 102(9):1046-1056.
26. Jabs A., Moncada G.A., Nichols C.E., Waller E.K., Wilcox J.N. Peripheral blood mononuclear cells acquire myofibroblast characteristics in granulation tissue. J Vasc Res 2005, 42(2):174-180.
27. Welt F.G., Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002, 22(11):1769-1776.
28. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8(4):403-409.
29. Zernecke A., Schober A., Bot I., von Hundelshausen P., Liehn E.A., Mopps B., et al. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 2005, 96(7):784-791.
30. Wang C.H., Anderson N., Li S.H., Szmitko P.E., Cherng W.J., Fedak P.W., et al. Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate. Circ Res 2006, 99(6):617-625.
31. Tanaka K., Sata M., Natori T., Kim-Kaneyama J.R., Nose K., Shibanuma M., et al. Circulating progenitor cells contribute to neointimal formation in nonirradiated chimeric mice. FASEB J 2008, 22(2):428-436.
32. Tanaka K., Sata M., Hirata Y., Nagai R. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res 2003, 93(8):783-790.
33. Hillebrands J.L., Klatter F.A., van Dijk W.D., Rozing J. Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat Med 2002, 8(3):194-195.
34. Hoofnagle M.H., Wamhoff B.R., Owens G.K. Lost in transdifferentiation. J Clin Invest 2004, 113(9):1249-1251.
35. Pollman M.J., Hall J.L., Mann M.J., Zhang L., Gibbons G.H. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat Med 1998, 4(2):222-227.
36. Prokopi M., Pula G., Mayr U., Devue C., Gallagher J., Xiao Q., et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 2009, 114(3):723-732.
37. Wang X., Willenbring H., Akkari Y., Torimaru Y., Foster M., Al-Dhalimy M., et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003, 422(6934):897-901.
38. Nygren J.M., Jovinge S., Breitbach M., Sawen P., Roll W., Hescheler J., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004, 10(5):494-501.
39. Tanaka K., Sata M. Contribution of circulating vascular progenitors in lesion formation and vascular healing: lessons from animal models. Curr Opin Lipidol 2008, 19(5):498-504.
40. Hoofnagle M.H., Thomas J.A., Wamhoff B.R., Owens G.K. Origin of neointimal smooth muscle: we've come full circle. Arterioscler Thromb Vasc Biol 2006, 26(12):2579-2581.
41. Bentzon J.F., Sondergaard C.S., Kassem M., Falk E. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 2007, 116(18):2053-2061.
42. Hillebrands J.L., Klatter F.A., van den Hurk B.M., Popa E.R., Nieuwenhuis P., Rozing J. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 2001, 107(11):1411-1422.
43. Hillebrands J.L., Klatter F.A., Rozing J. Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. Arterioscler Thromb Vasc Biol 2003, 23(3):380-387.
44. Shimizu K., Sugiyama S., Aikawa M., Fukumoto Y., Rabkin E., Libby P., et al. Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy. Nat Med 2001, 7(6):738-741.
45. Hu Y., Davison F., Ludewig B., Erdel M., Mayr M., Url M., et al. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 2002, 106(14):1834-1839.
46. Hu Y., Zhang Z., Torsney E., Afzal A.R., Davison F., Metzler B., et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 2004, 113(9):1258-1265.
47. Yoder M.C. Defining human endothelial progenitor cells. J Thromb Haemost 2009, 7(Suppl. 1):49-52.
48. Perlman H., Maillard L., Krasinski K., Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 1997, 95(4):981-987.
49. Costa M.A., Simon D.I. Molecular basis of restenosis and drug-eluting stents. Circulation 2005, 111(17):2257-2273.
50. Iwata H., Manabe I., Fujiu K., Takeda N., Eguchi K., Sata M., et al. Abstract 5429: Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth mucle cell lineages. Circulation 2009, 120:S1090-S1091.
51. Rodriguez-Menocal L., St-Pierre M., Wei Y., Khan S., Mateu D., Calfa M., et al. The origin of post-injury neointimal cells in the rat balloon injury model. Cardiovasc Res 2009, 81(1):46-53.
52. Passman J.N., Dong X.R., Wu S.P., Maguire C.T., Hogan K.A., Bautch V.L., et al. A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells. Proc Natl Acad Sci USA 2008, 105(27):9349-9354.
53. Bentzon J.F., Falk E. Circulating smooth muscle progenitor cells in atherosclerosis and plaque rupture: Current perspective and methods of analysis. Vascul Pharmacol 2010, 52(1-2):11-20.
54. Caplice N.M., Bunch T.J., Stalboerger P.G., Wang S., Simper D., Miller D.V., et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci USA 2003, 100(8):4754-4759.
55. Deb A., Wang S., Skelding K.A., Miller D., Simper D., Caplice N.M. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation 2003, 107(9):1247-1249.
56. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428(6983):664-668.
57. Atkinson C., Horsley J., Rhind-Tutt S., Charman S., Phillpotts C.J., Wallwork J., et al. Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin. J Heart Lung Transplant 2004, 23(4):427-435.
58. Assmus B., Honold J., Schachinger V., Britten M.B., Fischer-Rasokat U., Lehmann R., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006, 355(12):1222-1232.
59. Assmus B., Walter D.H., Lehmann R., Honold J., Martin H., Dimmeler S., et al. Intracoronary infusion of progenitor cells is not associated with aggravated restenosis development or atherosclerotic disease progression in patients with acute myocardial infarction. Eur Heart J 2006, 27(24):2989-2995.